NELARABINE 250 MG INJECTION
ARRANON (nelarabine) Injection is supplied as a clear, colorless, sterile solution in glass vials. Each 258 vial contains 250 mg of nelarabine (5 mg nelarabine per mL) and the inactive ingredient sodium 259 chloride (4.5 mg per mL) in 50 mL Water for Injection, USP. ARRANON is intended for 260 intravenous infusion.
ARRANON (nelarabine) - 250 mg/50 mL (5 mg/mL) vial
"As per Recommendation by Company:
Adult dose: 1,500 mg/m² administered intravenously over 2 hours on days 1, 3, and 5 repeated every 21 days.
Pediatric dose: 650 mg/m² administered intravenously over 1 hour daily for 5 consecutive days repeated every 21 days.
"
ARRANON (nelarabine) is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens.